Gaspoz J-M, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346:1800–6. doi:10.1056/NEJM200206063462309.
Article
PubMed
Google Scholar
Cadavid AP. Aspirin: the mechanism of action revisited in the context of pregnancy complications. Front Immunol. 2017;8:261. doi:10.3389/fimmu.2017.00261.
Article
PubMed
PubMed Central
Google Scholar
Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20:229–39. doi:10.1053/j.ackd.2013.01.014.
Article
PubMed
PubMed Central
Google Scholar
Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev 2002:CD001231. doi:10.1002/14651858.CD001231.
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. The Lancet. 2007;369:1791–8. doi:10.1016/S0140-6736(07)60712-0.
CAS
Article
Google Scholar
Woelkers D, Barton J, von Dadelszen P, Sibai B. The revised 2013 ACOG definitions of hypertensive disorders of pregnancy significantly increase the diagnostic prevalence of preeclampsia. Pregnancy Hypertens Int J Womens Cardiovasc Health. 2015;5:38. doi:10.1016/j.preghy.2014.10.075.
Google Scholar
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–7. doi:10.1053/j.semperi.2009.02.010.
Article
PubMed
Google Scholar
von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Hypertens Rep. 2014;16:1–14. doi:10.1007/s11906-014-0454-8.
Google Scholar
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. doi:10.1016/S2214-109X(14)70227-X.
Article
PubMed
Google Scholar
Lafont O. From the willow to aspirin. Rev Hist Pharm. 2007;55:209–16.
Article
Google Scholar
Botting RM. Vane’s discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. Pharmacol Rep PR. 2010;62:518–25.
CAS
Article
PubMed
Google Scholar
West GB. Aspirin and the prostaglandins. Chem Drug. 1972;198:196–7.
CAS
PubMed
Google Scholar
Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259:315.
CAS
Article
PubMed
PubMed Central
Google Scholar
Mitchell JA, Ahmetaj-Shala B, Kirkby NS, Wright WR, Mackenzie LS, Reed DM, et al. Role of prostacyclin in pulmonary hypertension. Glob Cardiol Sci Pract. 2014;2014:382. doi:10.5339/gcsp.2014.53.
PubMed
PubMed Central
Google Scholar
Maclouf J, Bellucci S. Role of prostaglandins and thromboxanes in cardiovascular physiopathology. Presse Medicale Paris Fr. 1983;1985(14):1603–6.
Google Scholar
Bowen RS, Zhang Y, Gu Y, Lewis DF, Wang Y. Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta. 2005;26:402–9. doi:10.1016/j.placenta.2004.07.007.
CAS
Article
PubMed
Google Scholar
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA. 1993;90:11693–7.
CAS
Article
PubMed
PubMed Central
Google Scholar
Lu Y, Wahl LM. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol Baltim Md. 1950;2005(175):5423–9.
Google Scholar
Chiang N, Serhan CN. Aspirin triggers formation of anti-inflammatory mediators: new mechanism for an old drug. Discov Med. 2004;4:470–5.
PubMed
Google Scholar
Takahashi Y. Molecular structure and regulation of cyclooxygenase. Nihon Rinsho Jpn J Clin Med. 1992;50:259–63.
CAS
Google Scholar
Trnavský K, Zachar M. Correlation of serum aspirin esterase activity and half-life of salicylic acid. Agents Actions. 1975;5:549–52.
Article
PubMed
Google Scholar
Bojić M, Sedgeman CA, Nagy LD, Guengerich FP. Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2015;73:49–56. doi:10.1016/j.ejps.2015.03.015.
Google Scholar
Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985;72:1177–84.
CAS
Article
PubMed
Google Scholar
Patrono C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci. 1989;10:453–8. doi:10.1016/S0165-6147(89)80010-0.
CAS
Article
PubMed
Google Scholar
Das UN. COX-2 inhibitors and metabolism of essential fatty acids. Med Sci Monit Int Med J Exp Clin Res. 2005;11:RA233–7.
CAS
Google Scholar
Patrick J, Dillaha L, Armas D, Sessa WC. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation. Postgrad Med. 2015;127:573–80. doi:10.1080/00325481.2015.1050341.
Article
PubMed
Google Scholar
Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol. 1989;74:551–7.
CAS
PubMed
Google Scholar
Roberts MS, Joyce RM, McLeod LJ, Vial JH, Seville PR. Slow-release aspirin and prostaglandin inhibition. Lancet Lond Engl. 1986;1:1153–4.
CAS
Article
Google Scholar
Caron N, Rivard G-E, Michon N, Morin F, Pilon D, Moutquin J-M, et al. Low-dose ASA response using the PFA-100 in women with high-risk pregnancy. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2009;31:1022–7.
Google Scholar
Wegert W, Graff J, Kaiser D, Breddin HK, Klinkhardt U, Harder S. Effects of antiplatelet agents on platelet-induced thrombin generation. Int J Clin Pharmacol Ther. 2002;40:135–41.
CAS
Article
PubMed
Google Scholar
Basinski A, Naylor CD. Aspirin and fibrinolysis. Lancet Lond Engl. 1988;2:1188–9.
CAS
Article
Google Scholar
Chen Y-H, Lin S-J, Chen Y-L, Liu P-L, Chen J-W. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets. 2006;6:279–304.
CAS
Article
PubMed
Google Scholar
Kim J, Lee K-S, Kim J-H, Lee D-K, Park M, Choi S, et al. Aspirin prevents TNF-α-induced endothelial cell dysfunction by regulating the NF-κB-dependent miR-155/eNOS pathway: role of a miR-155/eNOS axis in preeclampsia. Free Radic Biol Med. 2017;104:185–98. doi:10.1016/j.freeradbiomed.2017.01.010.
CAS
Article
PubMed
Google Scholar
Doridot L, Passet B, Méhats C, Rigourd V, Barbaux S, Ducat A, et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertens Dallas Tex. 1979;2013(61):662–8. doi:10.1161/HYPERTENSIONAHA.111.202994.
Google Scholar
Erdemli HK, Yıldırımlar P, Alper TY, Kocabaş R, Salis O, Bedir A. Increased serum heme oxygenase-1 levels as a diagnostic marker of oxidative stress in preeclampsia. Hypertens Pregnancy. 2014;33:488–97. doi:10.3109/10641955.2014.946613.
CAS
Article
PubMed
Google Scholar
Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30:260–79. doi:10.3109/07420528.2012.717455.
CAS
Article
PubMed
Google Scholar
Bonten TN, Saris A, van Oostrom MJ, Snoep JD, Rosendaal FR, Zwaginga J, et al. Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. Thromb Haemost. 2014;112:1209–18. doi:10.1160/TH14-05-0453.
CAS
Article
PubMed
Google Scholar
Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2004;70:223–32.
CAS
Article
PubMed
Google Scholar
Lecarpentier E, Haddad B, Goffinet F, Tsatsaris V. Moyens thérapeutiques de la prise en charge de la pré-éclampsie. Presse Médicale. 2016;. doi:10.1016/j.lpm.2016.04.017.
Google Scholar
Mousa AA, Strauss JF, Walsh SW. Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia. Hypertension. 2012;59:1249–55. doi:10.1161/hypertensionaha.111.188730.
CAS
Article
PubMed
PubMed Central
Google Scholar
Panagodage S, Yong HE, Da Silva Costa F, Borg AJ, Kalionis B, Brennecke SP, Murthi P. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol. 2016;186(12):3217–24.
CAS
Article
PubMed
Google Scholar
Scazzocchio E, Oros D, Diaz D, Ramirez JC, Ricart M, Meler E, et al. Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11–14 weeks: a randomized controlled study. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2017;49:435–41. doi:10.1002/uog.17351.
CAS
Article
Google Scholar
Walsh SW. Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia. Am J Perinatol. 1989;6:124–32. doi:10.1055/s-2007-999562.
CAS
Article
PubMed
Google Scholar
Perneby C, Vahter M, Åkesson A, Bremme K, Hjemdahl P. Thromboxane metabolite excretion during pregnancy – influence of preeclampsia and aspirin treatment. Thromb Res. 2011;127:605–6. doi:10.1016/j.thromres.2011.01.005.
CAS
Article
PubMed
Google Scholar
Li C, Raikwar NS, Santillan MK, Santillan DA, Thomas CP. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. Placenta. 2015;36:446–53. doi:10.1016/j.placenta.2015.01.004.
CAS
Article
PubMed
PubMed Central
Google Scholar
Vieillefosse S, Guibourdenche J, Atallah A, Haddad B, Fournier T, Tsatsaris V, et al. Predictive and prognostic factors of preeclampsia: interest of PlGF and sFLT-1. J Gynecol Obstet Biol Reprod (Paris). 2016;45:999–1008. doi:10.1016/j.jgyn.2016.02.006.
CAS
Article
Google Scholar
Tsatsaris V, Goffin F, Munaut C, Brichant J-F, Pignon M-R, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555–63. doi:10.1210/jc.2003-030528.
CAS
Article
PubMed
Google Scholar
Craven LL. Prevention of coronary and cerebral thrombosis. Miss Val Med J Quincy Ill. 1956;78:213–5.
CAS
Google Scholar
Beaufils M, Donsimoni R, Uzan S, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. The Lancet. 1985;325:840–2. doi:10.1016/S0140-6736(85)92207-X.
Article
Google Scholar
Uzan S, Beaufils M, Breart G, Uzan S, Bazin B, Capitant C, et al. Originally published as Volume 1, Issue 8755Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. The Lancet. 1991;337:1427–31. doi:10.1016/0140-6736(91)93124-R.
CAS
Article
Google Scholar
Anonymous. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994;343(8898):619–29.
Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 1998;338:701–5. doi:10.1056/NEJM199803123381101.
CAS
Article
PubMed
Google Scholar
Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ. 2001;322:329–33.
CAS
Article
PubMed
PubMed Central
Google Scholar
Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. In: The Cochrane Collaboration (ed). Cochrane Database Syst. Rev. Wiley, Chichester; 2007.
Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14. doi:10.1097/AOG.0b013e3181e9322a.
Article
PubMed
Google Scholar
Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol. 2017;216(121–128):e2. doi:10.1016/j.ajog.2016.10.016.
Google Scholar
Henderson JT, Whitlock EP, O’Conner E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive services task force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014.
ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159–67.
Article
Google Scholar
Werner EF, Hauspurg AK, Rouse DJ. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol. 2015;126:1242–50.
CAS
Article
PubMed
Google Scholar
Sibai BM. Therapy: low-dose aspirin to reduce the risk of pre-eclampsia? Nat Rev Endocrinol. 2015;11:6–8. doi:10.1038/nrendo.2014.199.
CAS
Article
PubMed
Google Scholar
MOUNIER-VEHIER C. Consensus d’Experts de la Société Française d’Hypertension Artérielle 2015. http://www.sfhta.eu/wp-content/uploads/2015/11/Recommandations_HTA_et_grossesse_dec_2015202.pdf. Accessed 19 June 2016.
Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:695–703. doi:10.7326/M13-2844.
Article
PubMed
Google Scholar
Practice Advisory on Low-Dose Aspirin and Prevention of Preeclampsia: Updated Recommendations—ACOG n.d. http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Prevention-of-Preeclampsia-Updated-Recommendations. Accessed 20 Apr 2017.
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary n.d. https://sogc.org/wp-content/uploads/2014/05/gui307CPG1405Erev.pdf.
Hypertension in pregnancy: diagnosis and management | Guidance and guidelines | NICE n.d. https://www.nice.org.uk/guidance/CG107. Accessed 20 Apr 2017.
Guidance regarding the use of low-dose aspirin in the prevention of pre-eclampsia in high-risk women. n.d. https://www.midwife.org.nz/.
Krieger VI, Weiden S. The value of the cold pressor test in the prediction of hypertension and toxaemia in pregnancy. Med J Aust. 1947;1:417–23.
CAS
PubMed
Google Scholar
Parra-Cordero M, Turan OM, Kaur A, Pearson JD, Nicolaides KH. Maternal serum soluble adhesion molecule levels at 11 + 0-13 + 6 weeks and subsequent development of pre-eclampsia. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2007;20:793–6. doi:10.1080/14767050701500349.
CAS
Google Scholar
Caradeux J, Serra R, Nien J-K, Pérez-Sepulveda A, Schepeler M, Guerra F, et al. First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study. Prenat Diagn. 2013;33:732–6. doi:10.1002/pd.4113.
Article
PubMed
Google Scholar
Scazzocchio E, Figueras F, Crispi F, Meler E, Masoller N, Mula R, et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol. 2013;208:203.e1–10. doi:10.1016/j.ajog.2012.12.016.
Article
Google Scholar
Odibo AO, Patel KR, Spitalnik A, Odibo L, Huettner P. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol Off J Calif Perinat Assoc. 2014;34:186–91. doi:10.1038/jp.2013.176.
CAS
Article
Google Scholar
Parra-Cordero M, Rodrigo R, Barja P, Bosco C, Rencoret G, Sepúlveda-Martinez A, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2013;41:538–44. doi:10.1002/uog.12264.
CAS
Article
Google Scholar
Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30:742–9. doi:10.1002/uog.5157.
CAS
Article
PubMed
Google Scholar
Villa PM, Kajantie E, Räikkönen K, Pesonen A-K, Hämäläinen E, Vainio M, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG Int J Obstet Gynaecol. 2013;120:64–74. doi:10.1111/j.1471-0528.2012.03493.x.
CAS
Article
Google Scholar
Poon LCY, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertens Dallas Tex. 1979;2009(53):812–8. doi:10.1161/HYPERTENSIONAHA.108.127977.
Google Scholar
Oliveira N, Doyle LE, Atlas RO, Jenkins CB, Blitzer MG, Baschat AA. External validity of first-trimester algorithms in the prediction of pre-eclampsia disease severity. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2014;44:286–92. doi:10.1002/uog.13433.
CAS
Article
Google Scholar
Oliveira N, Magder LS, Blitzer MG, Baschat AA. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2014;44:279–85. doi:10.1002/uog.13435.
CAS
Article
Google Scholar
O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1–12. doi:10.1016/j.ajog.2015.08.034.
Article
Google Scholar
Rolnik D, Wright D, Poon L, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;. doi:10.1056/NEJMoa1704559.
PubMed
Google Scholar
Roberge S, Nicolaides KH, Desmers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(110–120):e6.
Google Scholar
Tan M, Koutoulas L, Wright D, Nicolaides KH, Poon L. A study protocol for the prospective validation study: screening programme for pre-eclampsia (SPREE). Ultrasound Obstet Gynecol. 2017;. doi:10.1002/uog.17467.
Google Scholar
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O’Gorman N, de Paco Matallana C, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2017;. doi:10.1002/uog.18816.
Google Scholar
Mahmoud AN, Elgendy AY, Rambarat C, Mahtta D, Elgendy IY, Bavry AA. Efficacy and safety of aspirin in patients with peripheral vascular disease: an updated systematic review and meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0175283. doi:10.1371/journal.pone.0175283.
Article
PubMed
PubMed Central
Google Scholar
Chen W-C, Lin K-H, Huang Y-T, Tsai T-J, Sun W-C, Chuah S-K, et al. The risk of lower gastrointestinal bleeding in low-dose aspirin users. Aliment Pharmacol Ther. 2017;. doi:10.1111/apt.14079.
Google Scholar
Benito-Garcia E, Michaud K, Wolfe F. The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors. J Rheumatol. 2007;34:1765–9.
CAS
PubMed
Google Scholar
Belcon MC, Rooney PJ, Tugwell P. Aspirin and gastrointestinal haemorrhage: a methodologic assessment. J Chronic Dis. 1985;38:101–11.
CAS
Article
PubMed
Google Scholar
Stevenson DD, White AA, Simon RA. Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2012;129:1687–8. doi:10.1016/j.jaci.2012.04.016.
CAS
Article
PubMed
Google Scholar
Kennedy JL, Stoner AN, Borish L. Aspirin-exacerbated respiratory disease: prevalence, diagnosis, treatment, and considerations for the future. Am J Rhinol Allergy. 2016;30:407–13. doi:10.2500/ajra.2016.30.4370.
Article
PubMed
PubMed Central
Google Scholar
Lei H, Gao Q, Liu S-R, Xu J. The benefit and safety of aspirin for primary prevention of ischemic stroke: a meta-analysis of randomized trials. Front Pharmacol. 2016;7:440. doi:10.3389/fphar.2016.00440.
Article
PubMed
PubMed Central
Google Scholar
Leonhardt A, Bernert S, Watzer B, Schmitz-Ziegler G, Seyberth HW. Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics. 2003;111:e77–81. doi:10.1542/peds.111.1.e77.
Article
PubMed
Google Scholar
Jacobson RL, Brewer A, Eis A, Siddiqi TA, Myatt L. Transfer of aspirin across the perfused human placental cotyledon. Am J Obstet Gynecol. 1991;165:939–44.
CAS
Article
PubMed
Google Scholar
Hertz-Picciotto I, Hopenhayn-Rich C, Golub M, Hooper K. The risks and benefits of taking aspirin during pregnancy. Epidemiol Rev. 1990;12:108–48.
CAS
Article
PubMed
Google Scholar
Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. Lancet Lond Engl. 1976;1:1373–5.
CAS
Article
Google Scholar
Klebanoff MA, Berendes HW. Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology. 1988;37:249–55. doi:10.1002/tera.1420370310.
CAS
Article
PubMed
Google Scholar
Werler MM, Mitchell AA, Shapiro S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med. 1989;321:1639–42. doi:10.1056/NEJM198912143212404.
CAS
Article
PubMed
Google Scholar
Nørgård B, Puhó E, Czeizel AE, Skriver MV, Sørensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol. 2005;192:922–3. doi:10.1016/j.ajog.2004.10.598.
Article
PubMed
Google Scholar
Sasidharan CK, Kutty PM, Ajithkumar, Sajith N. Fetal intracranial hemorrhage due to antenatal low dose aspirin intake. Indian J Pediatr. 2001;68(11):1071–2.
Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 1998;105:286–92.
CAS
Article
PubMed
Google Scholar
Di Sessa TG, Moretti ML, Khoury A, Pulliam DA, Arheart KL, Sibai BM. Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Obstet Gynecol. 1994;171:892–900.
Article
PubMed
Google Scholar
Schiessl B, Schneider KT, Zimmermann A, Kainer F, Friese K, Oberhoffer R. Prenatal constriction of the fetal ductus arteriosus–related to maternal pain medication? Z Geburtshilfe Neonatol. 2005;209:65–8. doi:10.1055/s-2005-864116.
CAS
Article
PubMed
Google Scholar
Wyatt-Ashmead J. Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc. 2011;14:469–74. doi:10.2350/07-11-0368.1.
Article
Google Scholar